Chronic Therapies Drive 10% Growth in Indian Pharma Market

Long-term health management products, specifically chronic therapies, have been driving the growth of the Indian Pharmaceutical Market (IPM) with a 10% increase, in contrast to acute therapies which saw a 2% growth, showing a trend towards prolong...

Glenmark Becomes First Indian Company to Launch Biosimilar of Liraglutide

Glenmark became the first Indian company to introduce a biosimilar of the anti-diabetic GLP-1 drug Liraglutide in India. Additionally, it has revealed a number of collaborations to introduce new drugs, such as partnerships with Jiangsu Alphamab...

US Drives 30% Sales and 40% Volume for India Pharma

The United States continues to be a crucial market for the Indian pharmaceutical industry, representing approximately 30% of overall sales and capturing a 40% share of the market in terms of volume. Despite possible risks from changes in duty...

SPI Initiative Powers Pharma Clusters & MSMEs with 500 Cr Support

Strengthening of Pharmaceutical Industry (SPI)' initiative, backed by Rs 500 crore (USD 60.9 million) provides vital support to enhance productivity, quality and sustainability across pharma clusters and MSMEs nationwide....

Lubrizol Expands Medical Tubing Production Five-Fold for Global Export

The production facility of Lubrizol in India will expand its production of medical tubing by five times, improving availability of life-saving medical tubing locally and for global markets through exports. The collaboration will result in the...

How CRDMO Leaders can Leverage the BioSecure Act for New Opportunities

In an exclusive interview with India Pharma Outlook Magazine,Kapil Choudhury, Head of Global Business Development, Aurigene Pharmaceutical Services, shares how the Indian CRDMO leaders can equip themselves for the incoming business resulting from ...

Navigating the Future of Contract Research and Manufacturing Organizations

In an exclusive interaction with India Pharma Outlook, Dr. Mahesh Bhalgat, Group CEO and MD of Veeda Clinical Research Limited discusses key trends in the CRO/CDMO industry, such as digital transformation, niche specialization, global expansion...

Venus Remedies Gains PIC/S GMP Approval for Robotic Syringe Facility

Venus Remedies announced that its robotic pre-filled syringe facility at the Baddi unit has been granted approval for good manufacturing practices (GMP) by the National Pharmaceutical Regulatory Agency (NPRA) of Malaysia. Venus Remedies announced...

NPPA Issues Memorandum to Companies for Price Reduction on Cancer Drugs

The government has instructed companies to reduce the prices of three anti-cancer drugs in order to pass on the benefits from customs duty exemptions and reductions in GST to consumers. In line with the government’s commitment to ensuring that dru...

Latest Penicillin Plant Boasts Production Capacity of 15,000MT

Lyfius Pharma, a unit of Aurobindo Pharma, on Tuesday said Prime Minister Narendra Modi has inaugurated its Penicillin-G plant at Kakinada, Andhra Pradesh. The facility with an annual production capacity of 15,000 metric tonnes (MT) was virtually ...